- Global Pharma News & Resources

ENT Surgical Devices Market Reckoned To Generate A CAGR of 5.5% By 2027

The global ENT surgical devices market is estimated to value at over US$ 2 Bn in 2018, and is expected to register a CAGR of 5.5%. The report offers in-depth insights, revenue details, and other vital information regarding the global ENT surgical devices market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

ENT surgery is one of the most elaborated fields of surgical specialty services, using advanced technology and a broad range of procedures that include major reconstructive surgeries to correct deformity or injury. Increasing prevalence of ENT-related diseases and disorders is a key factor expected to drive growth of the global ENT surgical devices market over the forecast period. ENT specialists treat various ear conditions such as otosclerosis, age-related hearing loss, ear infections, etc. Rapidly increasing aging population, coupled with increasing prevalence of hearing-related problems such as tinnitus among all age groups are among major factors expected to propel demand for ENT surgical devices in the near future.

The global ENT surgical devices market is segmented on the basis of product type, application, and region.

On the basis of type segmentation, the handheld instruments segment is expected to contribute major revenue share and is estimated to maintain its dominance over the forecast period. The handheld instruments segment is estimated to register highest CAGR of over 5.7%, owing to increasing demand for handheld instruments for ENT surgical treatment.

On the basis of application segmentation, the hospital segment is expected to contribute major revenue share of the market and is expected to maintain its dominance over the forecast period. The hospital segment is projected to register highest CAGR over 5.5% over the forecast period, owing to availability of various reimbursement policies in hospitals and increasing number of patent pool.

The market in Asia Pacific is expected to account for second-highest revenue share in the global ENT surgical devices market, owing to increasing incidence of various ENT diseases, presence of large patient pool, and increasing government initiatives for spreading awareness about treatment of various diseases, especially in emerging economies.

To Get Sample Copy of Report visit @

The market in Middle East & Africa is expected to contribute moderately to the global ENT surgical devices market. Humid climate and high presence of sand particles results in ear infections and sinusitis problems in several countries in the Middle East. Rising prevalence of ear infections and increasing demand for comprehensive ENT services are major factors driving growth of the ENT surgical devices market in the UAE.

Key Players are Medtronic plc, Johnson & Johnson (Acclarent Inc), Stryker Corporation, Smith & Nephew plc, Olympus Corporation, Braun Melsungen AG, KARL STORZ GmbH & Co. KG, Spiggle & Theis Medizintechnik GmbH, CONMED Corporation, Happersberger otopront GmbH, Zhejiang Tiansong Medical Instrument Co Ltd, Reda Instrumente GmbH, Cochlear Limited and HOYA Corporation (PENTAX Medical)

Editor Details

Last Updated: 14-Feb-2019